The National Agency for Food and Drug Administration and Control (NAFDAC) has called upon stakeholders in the healthcare sector to enhance their vigilance regarding Antimicrobial Resistance (AMR) and the management of Adverse Drug Reactions (ADRs). The agency emphasized the importance of collaborative efforts in monitoring and addressing these critical issues to safeguard public health. NAFDAC's initiative aims to promote awareness and encourage proactive measures among healthcare professionals, policymakers, and the general public to mitigate the risks associated with antimicrobial misuse and adverse drug effects.
Related Articles
Don't miss out on breaking stories and in-depth articles.